Skip to main content
Erschienen in: AIDS and Behavior 8/2011

01.11.2011 | Original Paper

A Comparison of the Efficacy of Two Interventions to Reduce HIV Risk Behaviors Among Drug Users

verfasst von: Clyde B. McCoy, Victor De Gruttola, Lisa Metsch, Mary Comerford

Erschienen in: AIDS and Behavior | Ausgabe 8/2011

Einloggen, um Zugang zu erhalten

Abstract

Numerous interventions have been developed and implemented to decrease risk behaviors which lead to HIV infection and transmission. These interventions have been differentially successful in reducing high risk behaviors in various populations. Testing and evaluation of the interventions have been subject to various degrees of rigor. The CDC recommends the use of interventions which have been rigorously tested and meet the standards for evidence based intervention rather than the continuation of the development of new interventions. Project RESPECT is an evidence based intervention that proved efficacious in increasing condom use among patients of STD clinics. We tested the efficacy of the RESPECT intervention against the NIDA standard intervention to determine if the RESPECT intervention was more effective in reducing high risk behaviors among drug users. Both interventions showed changes from baseline to follow-up; RESPECT was more effective than the NIDA standard intervention in reducing high risk sex behaviors.
Literatur
1.
Zurück zum Zitat Sogolow E, Peersnab G, Semaan S, Strouse D, Lyles C. The HIV/AIDS Prevention Research Synthesis Project: scope, methods, and study classification results. J Acquir Immune Defic Syndr. 2002;30(Suppl 1):S15–29.PubMed Sogolow E, Peersnab G, Semaan S, Strouse D, Lyles C. The HIV/AIDS Prevention Research Synthesis Project: scope, methods, and study classification results. J Acquir Immune Defic Syndr. 2002;30(Suppl 1):S15–29.PubMed
2.
Zurück zum Zitat Lyles CM, Kay LS, Crepaz N, et al. Best-evidence interventions: finding from a systematic review of HIV behavioral interventions for US populations at high risk, 2000–2004. Am J Public Health. 2007;97:133–43.PubMedCrossRef Lyles CM, Kay LS, Crepaz N, et al. Best-evidence interventions: finding from a systematic review of HIV behavioral interventions for US populations at high risk, 2000–2004. Am J Public Health. 2007;97:133–43.PubMedCrossRef
3.
Zurück zum Zitat Collins C, Harshbarger C, Sawyer R, Hamdallah M. The diffusion of effective behavioral interventions project: development, implementation, and lesions learned. AID Educ Prev. 2006;18(Suppl A):5–20.CrossRef Collins C, Harshbarger C, Sawyer R, Hamdallah M. The diffusion of effective behavioral interventions project: development, implementation, and lesions learned. AID Educ Prev. 2006;18(Suppl A):5–20.CrossRef
4.
Zurück zum Zitat Dworkin SL, Pinto RM, Hunter J, Rapkin B, Remien RH. Keeping the spirit of community partnerships alive in the scale up of HIV/AIDS prevention: critical reflections on the roll out of DEBI (Diffusion of Effective Behavioral Interventions). Am J Commun Psychol. 2008;42:51–9.CrossRef Dworkin SL, Pinto RM, Hunter J, Rapkin B, Remien RH. Keeping the spirit of community partnerships alive in the scale up of HIV/AIDS prevention: critical reflections on the roll out of DEBI (Diffusion of Effective Behavioral Interventions). Am J Commun Psychol. 2008;42:51–9.CrossRef
6.
Zurück zum Zitat Copenhaver M, Johnston B, Lee IC, Harman J, Carey M, Team TSR. Behavioral HIV risk reduction among people who inject drugs: meta-analytic evidence of efficacy. J Subst Abuse Treat. 2006;31:163–71.PubMedCrossRef Copenhaver M, Johnston B, Lee IC, Harman J, Carey M, Team TSR. Behavioral HIV risk reduction among people who inject drugs: meta-analytic evidence of efficacy. J Subst Abuse Treat. 2006;31:163–71.PubMedCrossRef
7.
Zurück zum Zitat Des Jarlais DC, Semaan S. HIV prevention for injecting drug users: the first 25 years and counting. Psychosom Med. 2008;70:606–11.PubMedCrossRef Des Jarlais DC, Semaan S. HIV prevention for injecting drug users: the first 25 years and counting. Psychosom Med. 2008;70:606–11.PubMedCrossRef
8.
Zurück zum Zitat Chitwood DD, Comerford M, Sanchez J. Prevalence and risk factors among sniffers, short-term injectors, and long term injectors of heroin. J Psychoact Drugs. 2003;35:445–53.CrossRef Chitwood DD, Comerford M, Sanchez J. Prevalence and risk factors among sniffers, short-term injectors, and long term injectors of heroin. J Psychoact Drugs. 2003;35:445–53.CrossRef
9.
Zurück zum Zitat McCoy CB, Lai S, Metsch L, Messiah SE, Zhao W. Injection drug use and crack cocaine smoking: independent and dual risk behaviors for HIV infection. Ann Epidemiol. 2004;14:535–42.PubMedCrossRef McCoy CB, Lai S, Metsch L, Messiah SE, Zhao W. Injection drug use and crack cocaine smoking: independent and dual risk behaviors for HIV infection. Ann Epidemiol. 2004;14:535–42.PubMedCrossRef
10.
Zurück zum Zitat Strathdee SA, Galai N, Safaiean M, Celentano DD, Vlahov D, Johnson L, Nelson KE. Sex differences in risk factors for HIV seroconversion among injection drug users: a 10-year perspective. Arch Intern Med. 2001;161(10):1281–8.PubMedCrossRef Strathdee SA, Galai N, Safaiean M, Celentano DD, Vlahov D, Johnson L, Nelson KE. Sex differences in risk factors for HIV seroconversion among injection drug users: a 10-year perspective. Arch Intern Med. 2001;161(10):1281–8.PubMedCrossRef
11.
Zurück zum Zitat Kral AH, Bluthenthal RN, Lorvick J, Gee L, Bacchetti P, Edlin BR. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk factor analysis. Lancet. 2001;357(9266):1397–401.PubMedCrossRef Kral AH, Bluthenthal RN, Lorvick J, Gee L, Bacchetti P, Edlin BR. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk factor analysis. Lancet. 2001;357(9266):1397–401.PubMedCrossRef
12.
Zurück zum Zitat Kamb ML, Fishbein M, Douglas JM, et al. Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: a randomized controlled trial. JAMA. 1998;280:1161–7.PubMedCrossRef Kamb ML, Fishbein M, Douglas JM, et al. Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: a randomized controlled trial. JAMA. 1998;280:1161–7.PubMedCrossRef
13.
Zurück zum Zitat National Institute on Drug Abuse. The standard intervention of the cooperative agreement program for AIDS community-based outreach/intervention research. Cooperative Agreement Steering Committee, January 9–10, 1992. National Institute on Drug Abuse. The standard intervention of the cooperative agreement program for AIDS community-based outreach/intervention research. Cooperative Agreement Steering Committee, January 9–10, 1992.
14.
Zurück zum Zitat Coyle SL, Needle RH, Normand J. Outreach-based HIV prevention for injection drug users: a review of published outcome data. Public Health Rep. 1998;113(Suppl 1):19–30.PubMed Coyle SL, Needle RH, Normand J. Outreach-based HIV prevention for injection drug users: a review of published outcome data. Public Health Rep. 1998;113(Suppl 1):19–30.PubMed
15.
Zurück zum Zitat Metcalf CA, Douglas JM, Malotte CK, et al. Relative efficacy of prevention counseling with rapid and standard HIV testing: a randomized, controlled trial (RESPECT-2). Sex Transm Dis. 2005;32(2):130–8.PubMedCrossRef Metcalf CA, Douglas JM, Malotte CK, et al. Relative efficacy of prevention counseling with rapid and standard HIV testing: a randomized, controlled trial (RESPECT-2). Sex Transm Dis. 2005;32(2):130–8.PubMedCrossRef
16.
Zurück zum Zitat Watters JK, Biernacki P. Targeted sampling: options for the study of hidden populations. Social Probl. 1989;36:416–30.CrossRef Watters JK, Biernacki P. Targeted sampling: options for the study of hidden populations. Social Probl. 1989;36:416–30.CrossRef
17.
Zurück zum Zitat Metsch LR, McCoy CB, Miles CC, Wohler B. Prevention myths and HIV risk reduction by active drug users. AIDS Educ Prev. 2004;16:150–9.PubMedCrossRef Metsch LR, McCoy CB, Miles CC, Wohler B. Prevention myths and HIV risk reduction by active drug users. AIDS Educ Prev. 2004;16:150–9.PubMedCrossRef
18.
Zurück zum Zitat Chitwood DD, Inciardi JA, McBride DC, McCoy CB, McCoy HV, Trapido E. A community approach to AIDS intervention. New York: Greenwood Press; 1991. Chitwood DD, Inciardi JA, McBride DC, McCoy CB, McCoy HV, Trapido E. A community approach to AIDS intervention. New York: Greenwood Press; 1991.
19.
Zurück zum Zitat Ajzen I, Fishbein M. Understanding attitudes and predicting social behavior. Englewood Cliffs, NJ: Prentice-Hall; 1980. Ajzen I, Fishbein M. Understanding attitudes and predicting social behavior. Englewood Cliffs, NJ: Prentice-Hall; 1980.
20.
21.
Zurück zum Zitat Marmor M, Des Jarlais DC, Cohen H, et al. Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City. AIDS. 1897;1:39–44. Marmor M, Des Jarlais DC, Cohen H, et al. Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City. AIDS. 1897;1:39–44.
22.
Zurück zum Zitat Booth RE, Kwiatkowski CF, Chitwood DD. Sex related HIV risk behaviors: differential risks among injection drug users, crack smokers, and injection drug users who smoke crack. Drug Alcohol Depend. 2000;58:219–26.PubMedCrossRef Booth RE, Kwiatkowski CF, Chitwood DD. Sex related HIV risk behaviors: differential risks among injection drug users, crack smokers, and injection drug users who smoke crack. Drug Alcohol Depend. 2000;58:219–26.PubMedCrossRef
23.
Zurück zum Zitat Chitwood DD, McCoy CB, Comerford M, Kitner K. The prevalence and incidence of HIV among injection drug users: a five year panel study. Popul Res Policy Rev. 1999;18:39–53.CrossRef Chitwood DD, McCoy CB, Comerford M, Kitner K. The prevalence and incidence of HIV among injection drug users: a five year panel study. Popul Res Policy Rev. 1999;18:39–53.CrossRef
24.
Zurück zum Zitat Schoenbaum EE, Hartel D, Selwyn PA, et al. Risk factors for human immunodeficiency virus infection in intravenous drug users. New Engl J Med. 1989;321:874–9.PubMedCrossRef Schoenbaum EE, Hartel D, Selwyn PA, et al. Risk factors for human immunodeficiency virus infection in intravenous drug users. New Engl J Med. 1989;321:874–9.PubMedCrossRef
25.
Zurück zum Zitat Hoffman JA, Klein H, Eber M, Crosby H. Frequency and intensity of crack use as predictors of women’s involvement in HIV-related sexual risk behaviors. Drug Alcohol Depend. 1999;58:227–36.CrossRef Hoffman JA, Klein H, Eber M, Crosby H. Frequency and intensity of crack use as predictors of women’s involvement in HIV-related sexual risk behaviors. Drug Alcohol Depend. 1999;58:227–36.CrossRef
26.
Zurück zum Zitat Wells EA, Calsyn DA, Saxon AJ, Greenberg DM. Using drugs to facilitate sexual behavior is associated with sexual variety among injection drug users. J Nerv Ment Dis. 1993;181:626–31.PubMedCrossRef Wells EA, Calsyn DA, Saxon AJ, Greenberg DM. Using drugs to facilitate sexual behavior is associated with sexual variety among injection drug users. J Nerv Ment Dis. 1993;181:626–31.PubMedCrossRef
27.
Zurück zum Zitat Perry JL, Carroll ME. The role of impulsive behavior in drug abuse. Psychopharmacology. 2008;200:1–26.PubMedCrossRef Perry JL, Carroll ME. The role of impulsive behavior in drug abuse. Psychopharmacology. 2008;200:1–26.PubMedCrossRef
28.
Zurück zum Zitat Valdiserri RO, Ogden LL, McCray E. Accomplishments in HIV prevention science: implications for stemming the epidemic. Nat Med. 2003;9:881–6.PubMedCrossRef Valdiserri RO, Ogden LL, McCray E. Accomplishments in HIV prevention science: implications for stemming the epidemic. Nat Med. 2003;9:881–6.PubMedCrossRef
29.
Zurück zum Zitat Metzger DS, Navaline H, Woody GE. Drug abuse treatment as AIDS prevention. Public Health Rep. 1998;113(Suppl 1):97–106.PubMed Metzger DS, Navaline H, Woody GE. Drug abuse treatment as AIDS prevention. Public Health Rep. 1998;113(Suppl 1):97–106.PubMed
30.
Zurück zum Zitat Friedmann PD, Lemon SC, Stein MD, D’Aunno TA. Accessibility of addiction treatment: results from a national survey of outpatient substance abuse treatment organizations. Health Serv Res. 2003;38:887–903.PubMedCrossRef Friedmann PD, Lemon SC, Stein MD, D’Aunno TA. Accessibility of addiction treatment: results from a national survey of outpatient substance abuse treatment organizations. Health Serv Res. 2003;38:887–903.PubMedCrossRef
31.
Zurück zum Zitat Steenrod S, Brisson A, McCarty D, Hodgkin D. Effects of managed care on programs and practices for the treatment of alcohol and drug dependence. Recent Dev Alcohol. 2001;15:51–71.PubMedCrossRef Steenrod S, Brisson A, McCarty D, Hodgkin D. Effects of managed care on programs and practices for the treatment of alcohol and drug dependence. Recent Dev Alcohol. 2001;15:51–71.PubMedCrossRef
32.
Zurück zum Zitat Alexander JA, Nahra TA, Wheeler JRC. Managed care and access to substance abuse treatment services. J Behav Health Serv Res. 2003;30:161–75.PubMedCrossRef Alexander JA, Nahra TA, Wheeler JRC. Managed care and access to substance abuse treatment services. J Behav Health Serv Res. 2003;30:161–75.PubMedCrossRef
33.
Zurück zum Zitat Appel PW, Piculell R, Jansky HK, Griffy K. Assessing alcohol and other drug problems (AOD) among sexually transmitted disease (STD) clinic patients with a modified CAGE-A: Implications for AOD intervention services and STD prevention. Am J Drug Alcohol Abuse. 2006;32:129–53.CrossRef Appel PW, Piculell R, Jansky HK, Griffy K. Assessing alcohol and other drug problems (AOD) among sexually transmitted disease (STD) clinic patients with a modified CAGE-A: Implications for AOD intervention services and STD prevention. Am J Drug Alcohol Abuse. 2006;32:129–53.CrossRef
34.
Zurück zum Zitat Tsiatis A, Davidian M, Zhang M, Lu X. Covariate adjustment for two-sample treatment comparisons for randomized clinical trials: a principled yet flexible approach. Stat Med. 2008;27:4658–67.PubMedCrossRef Tsiatis A, Davidian M, Zhang M, Lu X. Covariate adjustment for two-sample treatment comparisons for randomized clinical trials: a principled yet flexible approach. Stat Med. 2008;27:4658–67.PubMedCrossRef
35.
Zurück zum Zitat Robins J, Rotnitzky A, Zhao L. Estimation of regression coefficients when some regressors are not always observed. J Am Stat Assoc. 1994;89:846–66.CrossRef Robins J, Rotnitzky A, Zhao L. Estimation of regression coefficients when some regressors are not always observed. J Am Stat Assoc. 1994;89:846–66.CrossRef
Metadaten
Titel
A Comparison of the Efficacy of Two Interventions to Reduce HIV Risk Behaviors Among Drug Users
verfasst von
Clyde B. McCoy
Victor De Gruttola
Lisa Metsch
Mary Comerford
Publikationsdatum
01.11.2011
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 8/2011
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-011-9975-1

Weitere Artikel der Ausgabe 8/2011

AIDS and Behavior 8/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.